Clinical Trial Update: Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients

View source ↗

Summary

Observations from the regular use of Faslodex (fulvestrant) in patients with advanced breast cancer from a terminated clinical trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Faslodex (fulvestrant)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Status: TERMINATED